Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: Possible involvement of multiple signal transduction and β-catenin/T-cell factor

Journal of Neuroimmunology

Volumn 155, Issue 1-2, 2004, Pages 21-31

  Lee, Eun Ok ^a   Shin, Yoo Jung ^a   Chong, Young Hae ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

catenin; Alzheimer's disease; PGE2; Tcf Lef signaling; TNF

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROSTAGLANDIN E1; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROTEIN KINASE C; SULPROSTONE; T CELL FACTOR PROTEIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ALZHEIMER DISEASE; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN D1; CYTOSKELETAL PROTEINS; DINOPROSTONE; DNA-BINDING PROTEINS; HUMANS; INFLAMMATION MEDIATORS; LYMPHOID ENHANCER-BINDING FACTOR 1; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PHOSPHOLIPASE C; PROTEIN KINASES; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444271426     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.05.012     Document Type: Article

References (50)

1. Ajmone-Cat M.A., Nicolini A., Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J. Neurochem. 87:2003;1193-1203
2. Aldskogius H., Liu L., Svensson M. Glial responses to synaptic damage and plasticity. J. Neurosci. Res. 58:1998;33-41
3. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22:1999;208-215
4. Blasko I., Grubeck-Loebenstein B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging. 20:2003;101-113
5. Chen C., Magee J.C., Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87:2002;2851-2857
6. Chong Y.H., Shin S.A., Lee H.J., Kang J.L., Suh Y.H. Molecular mechanisms underlying cyclic AMP inhibition of macrophage dependent TNF-α production and neurotoxicity in response to amyloidogenic C-terminal fragment of Alzheimer's amyloid precursor protein. J. Neuroimmunol. 133:2002;160-174
7. Chong Y.H., Shin Y.J., Suh Y.H. Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein. Mol. Pharmacol. 63:2003;690-698
8. Collins J.S., Perry R.T., Watson B. Jr., Harrell L.E., Acton R.T., Blacker D., Albert M.S., Tanzi R.E., Bassett S.S., McInnis M.G., Campbell R.D., Go R.C. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer disease genetics initiative. Am. J. Med. Genet. 96:2000;823-830
9. De Ferrari G.V., Chacon M.A., Barria M.I., Garrido J.L., Godoy J.A., Olivares G., Reyes A.E., Alvarez A., Bronfman M., Inestrosa N.C. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry. 8:2003;195-208
10. Dziewulska D., Mossakowski M.J. Cellular expression of tumor necrosis factor α and its receptors in human ischemic stroke. Clin. Neuropathol. 22:2003;35-40
11. Fujino H., West K.A., Regan J.W. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277:2002;2614-2619
12. Garcia Rodriguez L.A., Cattaruzzi C., Troncon M.G., Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch. Intern. Med. 158:1998;33-39
13. Garrido J.L., Godoy J.A., Alvarez A., Bronfman M., Inestrosa N.C. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J. 16:2002;1982-1984
14. Hirsch E.C., Breidert T., Rousselet E., Hunot S., Hartmann A., Michel P.P. The role of glial reaction and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 991:2003;214-228
15. Hoozemans J.J., Bruckner M.K., Rozemuller A.J., Veerhuis R., Eikelenboom P., Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J. Neuropathol. Exp. Neurol. 61:2002;678-688
16. Hoozemans J.J., Veerhuis R., Rozemuller A.J., Eikelenboom P. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease. Curr. Drug Targets. 4:2003;461-468
17. Hoshino T., Tsutsumi S., Tomisato W., Hwang H.J., Tsuchiya T., Mizushima T. Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J. Biol. Chem. 278:2003;12752-12758
18. Jho E., Lomvardas S., Costantini F.A. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Biochem. Biophys. Res. Commun. 266:1999;28-35
19. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155:1999;995-1004
20. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 70:2002;97-107
21. Kim H.S., Kim E.M., Lee J.P., Park C.H., Kim S., Seo J.H., Chang K.A., Yu E., Jeong S.J., Chong Y.H., Suh Y.H. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 17:2003;1951-1953
22. Kiriyama M., Ushikubi F., Kobayashi T., Hirata M., Sugimoto Y., Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 22:1997;217-224
23. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787
24. Lanzrein A.S., Johnston C.M., Perry V.H., Jobst K.A., King E.M., Smith A.D. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis. Assoc. Disord. 12:1998;215-227
25. Li Y.P., Bushnell A.F., Lee C.M., Perlmutter L.S., Wong S.K. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738:1996;196-204
26. Mattson M.P., Partin J., Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807:1998;167-176
27. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 357:2001;436-439
28. Montine T.J., Sidell K.R., Crews B.C., Markesbery W.R., Marnett L.J., Roberts L.J. II, Morrow J.D. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53:1999;1495-1498
29. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1999;1193-1226
30. Perry S.W., Dewhurst S., Bellizzi M.J., Gelbard H.A. Conflicting effects of TNF-α in normal and diseased brain: intraneural receptor crosstalk as one of the mechanism for explaining the paradox. J. Neurovirology. 8:2002;611-624
31. Petrova T.V., Akama K.T., Van Eldik L.J. Selective modulation of BV-2 microglial activation by prostaglandin E (2). Differential effects on endotoxin-stimulated cytokine induction. J. Biol. Chem. 274:1999;28823-28827
32. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. 92:1995;11294-11308
33. Rogers J., Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39:2001;333-340
34. Ruland J., Mak T.W. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol. Rev. 193:2003;93-100
35. Stalder A.K., Carson M.J., Pagenstecher A., Asensio V.C., Kincaid C., Benedict M., Powell H.C., Masliah E., Campell I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153:1998;767-783
36. Takahashi Y., Hayashi I., Tominari Y., Rikimaru K., Morohashi Y., Kan T., Natsugari H., Fukuyama T., Tomita T., Iwatsubo T.J. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J. Biol. Chem. 278:2003;18664-18670
37. Tarkowski E., Andreasen N., Tarkowski A., Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 74:2003;1200-1205
38. van Gool W.A., Aisen P.S., Eikelenboom P. Anti-inflammatory therapy in Alzheimer's disease: is hope still alive? J. Neurol. 250:2003;788-792
39. Venters H.D., Dantzer R., Kelley K.W. A new concept in neurodegeneration: TNFalpha is silencer of survival signals. Trends Neurosci. 23:2000;175-180
40. Viel J.J., McManus D.Q., Smith S.S., Brewer G.J. Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid. J. Neurosci. Res. 64:2001;454-465
41. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414:2001;212-216
42. Weggen S., Eriksen J.L., Sagi S.A., Pietrzik C.U., Ozols V., Fauq A., Golde T.E., Koo E.H. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J. Biol. Chem. 278:2003;31831-31837
43. Willert K., Nusse R. Beta-catenin: a key mediator of Wnt signaling. J. Biol. Chem. 273:1998;95-102
44. Wong P.T., McGeer P.L., McGeer E.G. Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem. Int. 21:1992;197-202
45. Yagami T., Nakazato H., Ueda K., Asakura K., Kuroda T., Hata S., Sakaeda T., Sakaguchi G., Itoh N., Hashimoto Y., Hiroshige T., Kambayashi Y. Prostaglandin E2 rescues cortical neurons from amyloid beta protein-induced apoptosis. Brain Res. 959:2003;328-335
46. Yang L., Lindholm K., Konishi Y., Li R., Shen Y. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22:2002;3025-3032
47. Yermakova A.V., O'Banion M.K. Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease. Neurobiol. Aging. 22:2001;823-836
48. Zhang J., Rivset S. Anti-inflammatory effects of prostaglandin E2 in the central system in response to brain injury and circulating lipopolysaccharide. J. Neurochem. 76:2001;855-864
49. Zhang Z., Hartmann H., Do V.M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Sommer B., van de Wetering M., Clevers H., Saftig P., De Strooper B., He X., Yankner B.A. Destabilization of b-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:1998;698-702
50. Zhao M., Cribbs D.H., Anderson A.J., Cummings B.J., Su J.H., Wasserman A.J., Cotman C.W. The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain. Neurochem. Res. 28:2003;307-318